Selected article for: "cardiovascular disease and increase age"
Author: Papazafiropoulou, Athanasia K.; Antonopoulos, Stavros
Title: The COVID-19 pandemic and diabetes mellitus
  • Cord-id: 4wyxt698
  • Document date: 2020_7_21
    • ID: 4wyxt698
    Snippet: COVID-19, a disease caused by a novel coronavirus, SARS-CoV-2, has reached the proportion of a pandemic and presents with either mild and moderate symptoms or in severe cases with acute respiratory distress syndrome, multiple organ dysfunction syndrome and even death. Older age, hypertension, cardiovascular disease, diabetes mellitus and obesity significantly increase morbidity and mortality in COVID-19 patients. In the present review we summarize the existing, and daily growing, data on the imp
    Document: COVID-19, a disease caused by a novel coronavirus, SARS-CoV-2, has reached the proportion of a pandemic and presents with either mild and moderate symptoms or in severe cases with acute respiratory distress syndrome, multiple organ dysfunction syndrome and even death. Older age, hypertension, cardiovascular disease, diabetes mellitus and obesity significantly increase morbidity and mortality in COVID-19 patients. In the present review we summarize the existing, and daily growing, data on the impact of COVID-19 infection on patients with diabetes, their antidiabetic therapy as well as the extra precautions, apart from good glucose control, they have to take in order not to contract the virus. Social distancing and strict hand hygiene are of great importance in order to help the global goal of eradication of the disease.

    Search related documents:
    Co phrase search for related documents
    • ace inhibit and acute ards respiratory distress syndrome: 1, 2, 3
    • ace inhibit and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4
    • ace inhibit and lung injury: 1, 2, 3
    • ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • ace inhibitor and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • ace inhibitor and adipose tissue: 1
    • ace inhibitor and lung disease: 1
    • ace inhibitor and lung injury: 1, 2, 3, 4
    • ace inhibitor arb and acute ards respiratory distress syndrome: 1, 2, 3
    • ace inhibitor arb and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6
    • ace inhibitor arb and lung injury: 1, 2
    • active form and acute ards respiratory distress syndrome: 1
    • active form and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • active form and adipose tissue: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and adipose tissue: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and low secretion: 1
    • acute ards respiratory distress syndrome and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars cov respiratory syndrome coronavirus and adipose tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute sars cov respiratory syndrome coronavirus and adipose tissue central nervous system: 1